Drugs Made In America Acquisition II Corp.

US$10.21As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:DMIIFinancials
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Shell Companies
Beta (5Y) —
PE TTM 41.72
TSR TTM —
Mkt cap US$650.4M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$9.98
(2.30%)
(91.18%)
Hold 10|6|12|8|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.10
0.10
0.12
0.12
0.61%
(4.98%)
9.60%
7.62%
Revenue$M
70.49
71.48
74.79
75.06
(0.78%)
(2.07%)
1.68%
4.71%
Peers (US$650.4M)
Cap (US$)
PE
597.7M
105.2x
541.5M
0.757x
Capital
TTM
5Y
10Y
Leveragex
9.189
—
—
EBIT/Intx
1.155
0.185
0.154
Own earn%
(16.99)
(204.22)
(200.48)
Sh yield%
28.34
57.15
56.17
Owners
Insiders/Inst%
5.83
20.57
Short interest%
2.57
SBC / revenue%
5.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
1–7
$1 testx
0.2
Incr. ROIC%
34